Form 4 for IPSC Century Therapeutics, Inc.

Accepted 2023-12-06 00:00:00 ET · period of report 2023-12-04 · accession 0001062993-23-022023 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2023-12-06	2023-12-04	IPSC	Pfeiffenberger Brent	Pres, CEO, Dir	A - Grant	$0.00	+1.45M	1.45M	New	$0
D	2023-12-06	2023-12-04	IPSC	Pfeiffenberger Brent	Pres, CEO, Dir	A - Grant	$0.00	+573.7K	573.7K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-12-04	A	A	1,173,775	$0.00	1,173,775	D	—	—	(F1) Reflects a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutics, Inc.'s (the "Company's") common stock. The RSUs underlying this grant shall vest 25% on December 4, 2024, with the remaining 75% vesting in one-twelfth (1/12th) increments on each of the first trading days on or after each of February 15, May 15, August 15, and November 15, subject to the Reporting Person's continued service through each applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
2	Common	Common Stock	2023-12-04	A	A	279,504	$0.00	1,453,279	D	—	—	(F2) Reflects a grant of RSUs. The RSUs underlying this grant shall vest in full on December 4, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
3	Derivative	Stock Option (right to buy)	2023-12-04	A	A	573,691	$0.00	573,691	D	$1.61 · — to 2033-12-04	573,691 Common Stock	(F3) The option vests 25% on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.